Wall Street Zen downgraded shares of AirSculpt Technologies (NASDAQ:AIRS – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday morning.
Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of AirSculpt Technologies in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce” and an average target price of $6.00.
View Our Latest Stock Report on AirSculpt Technologies
AirSculpt Technologies Stock Down 4.9%
Insider Transactions at AirSculpt Technologies
In other news, major shareholder Jorey Chernett bought 105,848 shares of the stock in a transaction on Monday, March 16th. The stock was purchased at an average price of $2.43 per share, for a total transaction of $257,210.64. Following the acquisition, the insider owned 6,592,059 shares in the company, valued at approximately $16,018,703.37. This trade represents a 1.63% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In the last three months, insiders bought 600,150 shares of company stock worth $1,404,424. 76.58% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of AIRS. Larson Financial Group LLC raised its position in AirSculpt Technologies by 20.4% in the 3rd quarter. Larson Financial Group LLC now owns 15,137 shares of the company’s stock valued at $121,000 after buying an additional 2,561 shares during the last quarter. Wexford Capital LP lifted its stake in AirSculpt Technologies by 2.6% in the 3rd quarter. Wexford Capital LP now owns 102,614 shares of the company’s stock valued at $823,000 after acquiring an additional 2,614 shares in the last quarter. Rhumbline Advisers boosted its position in AirSculpt Technologies by 16.1% during the 3rd quarter. Rhumbline Advisers now owns 20,782 shares of the company’s stock worth $167,000 after acquiring an additional 2,876 shares during the last quarter. Creative Planning grew its stake in shares of AirSculpt Technologies by 32.2% during the 2nd quarter. Creative Planning now owns 13,225 shares of the company’s stock worth $64,000 after acquiring an additional 3,224 shares in the last quarter. Finally, BNP Paribas Financial Markets grew its stake in shares of AirSculpt Technologies by 239.5% during the 3rd quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company’s stock worth $48,000 after acquiring an additional 4,199 shares in the last quarter. 91.54% of the stock is currently owned by institutional investors.
AirSculpt Technologies Company Profile
AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculptĀ® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.
Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.
Read More
Receive News & Ratings for AirSculpt Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AirSculpt Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
